Najwa Soussi
Publications by Year
Research Areas
Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Virus-based gene therapy research
Most-Cited Works
- → Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial(2015)420 cited
- → A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis(2016)45 cited
- → Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial(2023)34 cited
- Safety and adverse events(2016)
- Results of a Phase IIb non-viral gene therapy trial from the UK CF Gene Therapy Consortium(2014)
- Patient information sheets(2016)
- Assessment of immune responses to single and repeat dose aeroslisation of the non-viral formualtion PGM169/GL67A in cystic fibrosis patients(2014)
- Dose preparation sheet(2016)
- Results of mechanistic substudy(2016)
- Methods: clinical trial design and outcome measures(2016)